
Shared by @bmj_company ↗



Statins are the popular choice for lowering cholesterol, but could result in a sharp increase in the incidence of Type 2 diabetes.
Stronger safeguards are needed to ensure independent and transparent recommendations Glucagon-like peptide-1 (GLP-1) receptor agonists and related incretin based drugs have reshaped obesity management. Developed for type 2 diabetes, they improve glycaem



